BioLineRx Ltd. Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019
BioLineRx Ltd. (BLRX) had Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 of 0.1 ILS/shares as of 2025-12-31, per its 20-F filed 2026-03-23.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 · last filed 2026-03-23
- 2025-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 0.10 ILS/shares.
| Period end | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 |
|---|---|
| 2025-12-31 | 0.10 ILS/shares 20-F · filed 2026-03-23 |